Register for Newsletter

Startup

Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh
Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh
Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital
Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital
Merck Life Science India signs MoU with DPIIT
Merck Life Science India signs MoU with DPIIT
View More

Digitization

Healthcare Triangle launches Malaysian subsidiary QuantumNexis
Healthcare Triangle launches Malaysian subsidiary QuantumNexis
NVIDIA partners with Novo Nordisk and DCAI to advance drug discovery
NVIDIA partners with Novo Nordisk and DCAI to advance drug discovery
Wanbury to implement the SAP S/4 HANA private cloud platform
Wanbury to implement the SAP S/4 HANA private cloud platform
View More

Latest Stories

Biocon Biologics expands insulin access in Malaysia

Fredun Pharmaceuticals acquires One Pet Stop to foray into pet care market

Briefs: Neuland Laboratories and Granules India

Alembic announces USFDA final approval for single-dose vials

Sartorius expands manufacturing and R&D capacities for bioprocess solutions in France

Opinion
Injection filter needle market to reach $1.73 billion in 2025
Injection filter needle market to reach $1.73 billion in 2025
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging